BRIEF-Quantum Genomics announces design of its next phase II trial in arterial hypertension
* QUANTUM GENOMICS ANNOUNCES THE DESIGN OF ITS NEXT PHASE II TRIAL IN ARTERIAL HYPERTENSION, NEW-HOPE
Dec 14 Abano Healthcare Group Ltd :
* Unanimously recommends that shareholders reject partial takeover offer made by Healthcare Partners Holdings Limited
* Abano board recommends shareholders reject partial offer Source text for Eikon: Further company coverage:
AMSTERDAM, June 28 Philips, the Dutch medical equipment maker, said on Wednesday it will acquire U.S.-based Spectranetics Corp for 1.9 billion euros ($2.16 billion), including debt, in a deal agreed with the company's boards.